RBC Capital Markets adjusted their outlook on Morgan Stanley (NYSE:MS) shares, raising the price target from $122.00 to $142.00. The firm maintained a Sector Perform rating on the stock. The upgrade comes as Morgan Stanley's stock trades near its 52-week high of $136.

RBC Capital analyst Sabahat Khan maintained a Buy rating on Republic Services (RSG – Research Report) on January 27 and set a price target of

Bank stocks have been on a post-election upswing, with the KBW Nasdaq Bank Index ( ^BKX) up 14% since Trump won the presidency. Morgan Stanley has notched a 17% gain. Investors have a dinner plate to choose from to explain the bullishness.

RBC Capital analyst Brad Heffern maintained a Hold rating on UDR (UDR – Research Report) today and set a price target of $43.00. The company’s

Exelixis Inc (EXEL) stock saw a modest uptick, ending the day at $32.73 which represents a slight increase of $0.35 or 1.08% from the prior close of $32.38. The stock opened at $32.92 and touched a low of $32.

The CEO also said he is ‘bullish’ on the potential for stock sales, including initial public offerings in 2025.

Morgan Stanley's profit more than doubled in the fourth quarter, fueled by a wave of dealmaking and stock sales that drove its revenue to a full-year record.

NextEra Energy (NYSE:NEE – Free Report) had its price target upped by Morgan Stanley from $93.00 to $94.00 in a research report report published on Thursday,Benzinga reports. Morgan Stanley currently has an overweight rating on the utilities provider’s stock.

Daniel Fannon; Analyst; Jefferies & Company Inc. Gerard Cassidy; Analyst; RBC Capital Markets

MSCI Inc (NYSE:MSCI). reported its fourth-quarter 2024 earnings, exceeding analyst expectations with an EPS of $4.18 compared to the forecasted $3.96. Despite this positive surprise, the company's stock fell by 5.

RBC Capital analyst Matthew Hedberg maintained a Hold rating on F5 Networks (FFIV – Research Report) yesterday and set a price target of

NextEra Energy (NYSE:NEE – Get Free Report) had its target price upped by research analysts at BMO Capital Markets from $82.00 to $84.00 in a research report issued to clients and investors on Monday.